- Indian Heritage
- Culture
- Modern Indian history
- The Freedom Struggle
- Post-independence
- Indian Society
A. population and associated issues
B. poverty and developmental issues
C.urbanization
7. Geographical features
8.Indian Constitution
9. Polity
10. Governance
A. institutions
B. regulatory
C. Government policies
D. role of NGOs
E. measures
11. Social Justice
A. Welfare schemes
B Health
National Ayush Mission:
One of the initiatives is implementing a flagship scheme i.e., Centrally Sponsored Scheme of National Ayush Mission (NAM), to support the UT / State Governments in developing infrastructure and improving access to the Ayush healthcare.
Ministry of Ayush organized a 2-day National Ayush Mission (NAM) Conclave- State/UT Ayush/Health Ministers’ Conference on 18th and 19th May 2023 at Vigyan Bhawan, New Delhi. Shri Sarbananda Sonowal, Hon’ble Minister of Ayush and Ports, Shipping and Waterways inaugurated the Conclave. Dr. Mansukh Mandaviya, Union Minister of Health & Family Welfare was the chief guest on this occasion. Dr. Mahendrabhai Munjpara, Hon’ble Minister of State for Ayush and Women & Child Development and 13 Health & Ayush Ministers from participating States/UTS attended this Conclave. A roundtable discussion with Ayush & Health Ministers of various states was held on the sidelines of the NAM Conclave. During the inaugural session of this Conclave, E-Learning Management System (eLMS) and comprehensive AHMIS, an upgraded EHR system, were launched.
Further, through National Ayush Mission, Ministry of Ayush completed the process for approval for upgradation of 12,500 Health facilities into Ayush Health and Wellness Centre under the Ayushman Bharat. As per the data received from States/UTs, 8.42 Crores beneficiaries benefitted through these facilities during 2022-23 and 6.91 crores from January 2023 to October 2023.
Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP)
- Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP) is a flagship scheme of the Department whereby quality generic medicines are made available at affordable prices to all through dedicated outlets known as Pradhan Mantri Bhartiya Janaushadhi Kendras(PMBJK). The Scheme is being implemented through the Pharmaceuticals & Medical Devices Bureau of India (PMBI), an autonomous society under the Department of Pharmaceuticals. As on 30.11.2023, 10,006 Pradhan Mantri Bhartiya Janaushadhi Kendras (PMBJKs) have been opened across the country.
- Objectives of the Scheme is to make available quality medicines and surgical items at affordable prices for all and thereby reduce out of pocket expenditure of consumers/patients and popularize generic medicines among the masses.
- Product basket of PMBJP comprises 1965 medicines & 293 surgical equipment covering all major therapeutic groups such as Anti-infectives, Anti-diabetics, Cardiovasculars, Anti-cancers, Gastro-intestinal medicines, etc., which are available for sale through these kendras. In the year 2023, 206 medicines & 13 surgical equipment have been added in the product basket.
National Pharmaceutical Pricing Authority (NPPA):
The National Pharmaceutical Pricing Authority (NPPA), an independent body of experts in the Ministry of Chemicals and Fertilizers, Department of Pharmaceuticals was constituted by the Government of India vide resolution published in the Gazette of India No. 159 dated 29.08.97. The functions of NPPA, inter-alia, includes fixation and revision of prices of scheduled formulations under the extant Drugs (Prices Control) Order (DPCO), as well as monitoring and enforcement of prices. NPPA also provides inputs to Government on pharmaceutical policy and issues related to affordability, availability and accessibility of medicines.
Followings are the major achievement and initiatives for the period of January to December, 2023:
Fixation of Ceiling Price of drugs: NPPA fixes the ceiling price of formulation listed in Schedule-I of DPCO, 2013. Under the market-based approach adopted in DPCO, 2013. NPPA has fixed the ceiling prices of 915 formulations (700 formulations under NLEM 2022 & 215 formulations under NLEM 2015) under DPCO, 2013 till date. Out of these 700 formulations fixed under NLEM, 2022, ceiling prices for 581 formulations have been fixed in current calendar year. The fixation of ceiling prices of scheduled formulations listed in NLEM 2022 has enabled savings of Rs.3588 crore to the consumers.
National Biopharma Mission (NBM):
In alignment with the national missions of ‘’Make-in India’ and “AatmaNirbhar Bharat”, this cabinet approved industry- academia collaborative Mission is focused on enabling and nurturing an ecosystem for affordable biopharmaceutical and biomedical product development. NBM has enabled support for development of 15 vaccine candidates for cholera, influenza, dengue, chikungunya, pneumococcal disease, covid-19 (early development) and related technologies; 21 biosimilar products and related technologies for diabetes, rheumatological and ophthalmic diseases, cancer; 29 medical devices & diagnostics. Notable successes under NBM, during 2023 are:
- Development of a compact, lightweight, next generation MRI Scanner to solve the unmet need of the country. The combination of next generation hardware with software has enabled to successfully introduce a highly disruptive product in the diagnostic imaging space. This is the first Indian company to receive commercial sale and manufacture license from CDSCO, Govt of India.
- Market Authorization Approval (MAA) on 4th September, 2023, for the biosimilar Liraglutide after successful completion of Phase III clinical trial. This will be the First Biosimilar of Victoza in Indian market.
C. Education
D. Human Resources
E. poverty and hunger
12. International relations
A. India and its neighbourhood
B. groupings and agreements
C.Indian diaspora
13. Economic Development
A. Government Budgeting
B. industrial
Index of Eight Core Industries (ICI)
Coal, Electricity, Fertilizers, Natural Gas, Refinery Products and Steel record positive growth in Nov 2023
The combined Index of Eight Core Industries (ICI) increased by 7.8 per cent (provisional) in November 2023 as compared to the Index of November 2022. The production of Coal, Electricity, Fertilizers, Natural Gas, Refinery Products and Steel recorded positive growth in November 2023. The details of annual and monthly indices and growth rates are provided at Annex I and Annex II respectively.
The ICI measures combined and individual performance of production of eight core industries viz. Cement, Coal, Crude Oil, Electricity, Fertilizers, Natural Gas, Refinery Products and Steel. The Eight Core Industries comprise 40.27 percent of the weight of items included in the Index of Industrial Production (IIP).
The final growth rate of Index of Eight Core Industries for August 2023 is revised to 13.4 per cent. The cumulative growth rate of ICI during April to November, 2023-24 is 8.6 per cent (provisional) as compared to the corresponding period of last year.
The summary of the Index of Eight Core Industries is given below:
Cement – Cement production (weight: 5.37 per cent) decreased by 3.6 per cent in November, 2023 over November, 2022. Its cumulative index increased by 10.3 per cent during April to November, 2023-24 over corresponding period of the previous year.
Coal – Coal production (weight: 10.33 per cent) increased by 10.9 per cent in November, 2023 over November, 2022. Its cumulative index increased by 12.8 per cent during April to November, 2023-24 over corresponding period of the previous year.
Crude Oil – Crude Oil production (weight: 8.98 per cent) decreased by 0.4 per cent in November, 2023 over November, 2022. Its cumulative index declined by 0.2 per cent during April to November, 2023-24 over corresponding period of the previous year.
Electricity – Electricity generation (weight: 19.85 per cent) increased by 5.6 per cent in November, 2023 over November, 2022. Its cumulative index increased by 7.7 per cent during April to November, 2023-24 over corresponding period of the previous year.
Fertilizers – Fertilizer production (weight: 2.63 per cent) increased by 3.4 per cent in November, 2023 over November, 2022. Its cumulative index increased by 6.3 per cent during April to November, 2023-24 over corresponding period of the previous year.
Natural Gas – Natural Gas production (weight: 6.88 per cent) increased by 7.6 per cent in November, 2023 over November, 2022. Its cumulative index increased by 5.4 per cent during April to November, 2023-24 over corresponding period of the previous year.
Petroleum Refinery Products – Petroleum Refinery production (weight: 28.04 per cent) increased by 12.4 per cent in November, 2023 over November, 2022. Its cumulative index increased by 5.0 per cent during April to November, 2023-24 over corresponding period of the previous year.
Steel – Steel production (weight: 17.92 per cent) increased by 9.1 per cent in November, 2023 over November, 2022. Its cumulative index increased by 14.2 per cent during April to November, 2023-24 over corresponding period of the previous year.
E.issues
14. Technology
indian Space Policy – 2023
The Indian Space Policy-2023 was approved by the Cabinet Committee on Security and released in public domain. The Policy underwent extensive deliberations with industry groups and inter-ministerial consultations.
Achievements in Nuclear Power Programme
- AMD has made sustained exploration efforts and augmented additional Uranium Oxide reserves to cater to the nuclear power programme of the country.
- At NFC, indigenous development of Tungsten Copper composite material has resulted in reducing the costs by about 67% on the imported cost giving an annual saving of ₹ 2 Crore. For the first time in India, NFC has indigenously developed Inconel 740 H tubing for Advanced Ultra Super Critical (AUSC) applications. This technology will help power plants burn less coal for electricity production while reducing carbon dioxide emissions. In addition, NFC has been successfully fulfilling all the requirements of our domestic nuclear power reactors with respect to the fabrication of fuel and core structurals.
- KAPP – 3, the first indigenous 700 MW PHWR at Gujarat, has started full power commercial power production on 31st August and with this, the installed capacity of our nuclear power plants has reached 7480 MW. KAPP- 4 attained criticality on 17th December 2023 which is the first step for commercial operation of the plant.
- Towards the realization of the 2nd stage of our nuclear power program, significant developments have happened over the last one year. The filling of the Main Vessel of PFBR of BHAVINI with about 1,150 tonnes of liquid Sodium has been completed in a record time of 5 days in the month of August 2023. All the indigenously manufactured Primary and Secondary sodium pumps have been put in service successfully and integrated commissioning of the plant is in an advanced stage.
15. Environment
National Tiger Conservation Authority (NTCA)
- Project Tiger completes 50 years:- The Centrally Sponsored Scheme – Project Tiger that has put the endangered wild tigers of India on assured path of recovery has completed 50 years of successful implementation. A commemorative event “Commemoration of 50 years of Project Tiger” was inaugurated by Hon’ble Prime Minister of India in Mysuru, Karnataka on 9th April 2023. The Prime Minister also released the publications – ‘Amrit Kaal Ka Vision For Tiger Conservation’, a summary report of the 5th cycle of Management Effectiveness Evaluation of Tiger Reserves, summary report of All India Tiger Estimation (5th cycle) and declared tiger numbers. He also released a commemorative coin on the completion of 50 years of Project Tiger.
16. Security
17. Disaster Management